de Boer AH - Search Results

1

Challenges for pulmonary delivery of high powder doses.

Sibum I, Hagedoorn P, de Boer AH, Frijlink HW, Grasmeijer F. Sibum I, et al. Among authors: de boer ah. Int J Pharm. 2018 Sep 5;548(1):325-336. doi: 10.1016/j.ijpharm.2018.07.008. Epub 2018 Jul 2. Int J Pharm. 2018. PMID: 29991452 Free article. Review.

2

Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.

Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: de boer ah. Int J Pharm. 1999 Nov 5;189(2):205-14. doi: 10.1016/s0378-5173(99)00251-3. Int J Pharm. 1999. PMID: 10536249

3

Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.

Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: de boer ah. Int J Pharm. 1999 Nov 5;189(2):215-25. doi: 10.1016/s0378-5173(99)00252-5. Int J Pharm. 1999. PMID: 10536250

4

A review of the technical aspects of drug nebulization.

Le Brun PP, de Boer AH, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: de boer ah. Pharm World Sci. 2000 Jun;22(3):75-81. doi: 10.1023/a:1008786600530. Pharm World Sci. 2000. PMID: 11028259 Review.

5

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.

de Boer AH, Le Brun PP, van der Woude HG, Hagedoorn P, Heijerman HG, Frijlink HW. de Boer AH, et al. Eur J Pharm Biopharm. 2002 Jul;54(1):17-24. doi: 10.1016/s0939-6411(02)00043-7. Eur J Pharm Biopharm. 2002. PMID: 12084498

6

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.

Le Brun PP, de Boer AH, Mannes GP, de Fraîture DM, Brimicombe RW, Touw DJ, Vinks AA, Frijlink HW, Heijerman HG. Le Brun PP, et al. Among authors: de fraiture dm, de boer ah. Eur J Pharm Biopharm. 2002 Jul;54(1):25-32. doi: 10.1016/s0939-6411(02)00044-9. Eur J Pharm Biopharm. 2002. PMID: 12084499

7

The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation.

Dickhoff BH, Ellison MJ, de Boer AH, Frijlink HW. Dickhoff BH, et al. Among authors: de boer ah. Eur J Pharm Biopharm. 2002 Sep;54(2):245-8. doi: 10.1016/s0939-6411(02)00082-6. Eur J Pharm Biopharm. 2002. PMID: 12191698

8

Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique.

de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. de Boer AH, et al. Int J Pharm. 2002 Dec 5;249(1-2):219-31. doi: 10.1016/s0378-5173(02)00526-4. Int J Pharm. 2002. PMID: 12433450

9

Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols.

de Boer AH, Gjaltema D, Hagedoorn P, Schaller M, Witt W, Frijlink HW. de Boer AH, et al. Int J Pharm. 2002 Dec 5;249(1-2):233-45. doi: 10.1016/s0378-5173(02)00527-6. Int J Pharm. 2002. PMID: 12433451

10

Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.

Weda M, Zanen P, de Boer AH, Gjaltema D, Ajaoud A, Barends DM, Frijlink HW. Weda M, et al. Among authors: de boer ah. Int J Pharm. 2002 Dec 5;249(1-2):247-55. doi: 10.1016/s0378-5173(02)00533-1. Int J Pharm. 2002. PMID: 12433452 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page